CK7( [4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine )

Catalog No. M28803 CAS No. 507487-89-0

CK7, a Cdk2/9 inhibitor, can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	160	Get Quote
10MG	259	Get Quote
25MG	515	Get Quote
50MG	740	Get Quote
100MG	1017	Get Quote
500MG	2052	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CK7
Note

Research use only, not for human use.
Brief Description

CK7, a Cdk2/9 inhibitor, can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367.
Description

CK7, a Cdk2/9 inhibitor, can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367.
In Vitro

——
In Vivo

——
Synonyms

[4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine
Pathway

Angiogenesis
Target

CDK
Recptor

Δ5D
Research Area

——
Indication

——

Chemical Information

CAS Number

507487-89-0
Formula Weight

655.69
Molecular Formula

C28H23N12O4S2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 12.5 mg/mL (38.07 mM)
SMILES

Cc1c(-c2nc(Nc3cc([N+]([O-])=O)ccc3)ncc2)sc(N)n1Cc1c(-c2nc(Nc3cc([N+]([O-])=O)ccc3)ncc2)sc(N)n1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.T-3364366 Targets the Desaturase Domain of Delta-5 Desaturase with Nanomolar Potency and a Multihour Residence Time Ikuo Miyahisa, Hideo Suzuki, Atsushi Mizukami, Yukiya Tanaka, Midori Ono, Mark S. Hixon, and Junji Matsui Publication Date (Web): August 10, 2016 (Letter)

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks